Financial insights of SLQT

MyFinsight

For the quarter ending 2026-03-31, SLQT made $430,933K in revenue. $21,422K in net income. Net profit margin of 4.97%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue	430,933	537,102	328,811	529,943*
Cost of commissions and other services revenue	83,268	103,034	69,101	87,410*
Cost of goods soldpharmacy revenue	171,289	205,194	192,779	192,599*
Marketing and advertising	92,481	105,028	61,947	84,760*
Selling, general, and administrative	38,188	38,940	35,819	47,697*
Technical development	9,777	9,595	9,911	10,120*
Total operating costs and expenses	395,003	461,791	369,557	422,584*
Income from operations	35,930	75,311	-40,746	107,359*
Interest expense, net	10,602	11,613	11,808	14,228*
Change in fair value of warrants	-27,489	-19,296	-15,036	39,433*
Loss on extinguishment of debt	-8,659	-	-	-
Other expense, net	-34	-39	-145	-54*
Income before income tax expense	44,124	82,955	-37,663	53,643*
Income tax expense	3,927	13,662	-7,204	-26,226*
Net income	40,197	69,293	-30,459	79,869*
Change in cash flow hedge	-	-	-	4,243
Other comprehensive income (gain)	-	-	-	4,243*
Senior non-convertible preferred stock accumulated dividends and accretion	18,775	18,125	17,482	-
Comprehensive income (loss)	-	-	-	84,112
Net income attributable to common shareholders	21,422	51,168	-47,941	-

Basic EPS	0.11	0.27	-0.26	0.468
Diluted EPS	0.11	0.26	-0.26	0.446
Basic Average Shares	189,455,000	187,573,000	185,816,000	179,857,000
Diluted Average Shares	190,481,000	190,830,000	185,816,000	188,615,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.